NCT01552161 is a clinical trial in Coronary Artery Disease, sponsored by Medical University of Lodz.

Who is sponsoring NCT01552161?

NCT01552161 is sponsored by Medical University of Lodz.

What condition does NCT01552161 study?

NCT01552161 studies Coronary Artery Disease, Allergy, Asthma.

Is NCT01552161 still recruiting?

NCT01552161 is currently completed. Last updated 26 January 2014.

Last reviewed 2014-01-26 · How we verify

NCT01552161

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Prevalence of Allergic Diseases and Atopy in Patients With Angiographically Confirmed Coronary Artery Disease

Completed Last updated 26 January 2014

What this trial tests

trial in Coronary Artery Disease in 300 participants. Completed in 1 June 2012.

Timeline

1 April 2010

Primary endpoint
1 April 2012

1 June 2012

Quick facts

Lead sponsor	Medical University of Lodz
Status	Completed
Study type	OBSERVATIONAL
Enrollment	300
Start date	1 April 2010
Primary completion	1 April 2012
Estimated completion	1 June 2012
Sites	1 location across Poland

Conditions studied

Coronary Artery Disease — all drugs for Coronary Artery Disease →
Allergy — all drugs for Allergy →
Asthma — all drugs for Asthma →

Sponsor

Medical University of Lodz

Who can join

30 and older, any sex, with Coronary Artery Disease or Allergy. Patients with the condition only — healthy volunteers not accepted.

What's being measured

Primary outcomes are the specific endpoints the trial is designed to prove or disprove.

Prevalence of allergic diseases
Time frame: Within a month from study recruitment completion.
Asthma, allergic rhinitis, allergic concjunctivitis, atopic dermatitis, contact eczema, drug, food and insect venom allergy will be assessed through a structured questionnaire based on ISAAC and ECRHS questions regarding allergy symptoms. Additionally: Asthma diagnosis is verified through basic spirometry, reversibility test, skin prick tests and/or serum specific IgE. Allergic rhinitis diagnos

Sponsor's own description

The purpose of this study is to estimate the prevalence of allergic diseases and atopy among patients with angiographically confirmed coronary artery disease as well as to assess levels of serum allergic inflammation markers in this population.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Coronary Artery Disease

Currently open trials in the same condition.

NCT07399002 — LONG NAGOMI™ PMCF STUDY · recruiting
NCT07420582 — Antegrade Autologous Blood Reinfusion After CPB · recruiting
NCT07493603 — A Study on Yiyang Huoluo Decoction in the Treatment of Coronary Heart Disease · Phase 1, PHASE2 · recruiting
NCT06535568 — Single vs. Dual Antiplatelet Therapy in Elderly or HBR Patients Undergoing Percutaneous Intervention With DCB (PICCOLETO · NA · recruiting
NCT07286578 — A Prospective, Multicenter, Randomized Controlled Trial to Investigate the Value of Coronary CT Angiography in the Under · NA · recruiting

Other Medical University of Lodz trials

Trials by the same sponsor.

NCT07391969 — Evaluation of SaCo VLMA for General Anesthesia for Laparoscopic Procedures · NA · not yet recruiting
NCT06453317 — Comparison of Ustekinumab, Infliximab and Combination Therapy in Moderately to Severely Active Ulcerative Colitis · Phase 2 · recruiting
NCT06850597 — Efficacy and Safety of Dimethyl Fumarate Among Patients with Mild Cognitive Impairment and Dementia Due to Alzheimer's D · Phase 2 · recruiting
NCT06917300 — Virtual Reality as a Digital Premed to Alleviate Pain and Anxiety Preoperatively in Patients Undergoing Spine Surgery · NA · recruiting
NCT06391216 — The Effect of Probiotic Supplementation on Mental Health in Healthy Volunteers · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT01552161 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Medical University of Lodz
Last refreshed: 26 January 2014

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01552161.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing